[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Anti-ulcer Drugs Market Report to 2021

November 2016 | 103 pages | ID: EAA561C3F9DEN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Anti-ulcer Drugs

Revenue, means the sales value of Anti-ulcer Drugs

This report studies sales (consumption) of Anti-ulcer Drugs in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Novartis
  • Pfizer, Inc.
  • Roche
  • Sanofi
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • AstraZeneca plc.
  • Eli Lilly and Company
  • Abbvie
  • AMGen
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • Bristol-Myers Squibb
  • Astellas Pharma
  • Daiichi Sankyo
  • Abbott Laboratories
  • Yangtze River Pharmaceutical Group
  • BAX
  • Taishō Seiyaku Kabushiki-gaisha
Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Anti-ulcer Drugs in these regions, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Histamine H2 Receptor Antagonist
  • Proton Pump Inhibitor
  • Others
Split by applications, this report focuses on sales, market share and growth rate of Anti-ulcer Drugs in each application, can be divided into
  • First Level Hospital
  • Two Level Hospital
  • Three Level Hospital
  • Others
1 ANTI-ULCER DRUGS OVERVIEW

1.1 Product Overview and Scope of Anti-ulcer Drugs
1.2 Classification of Anti-ulcer Drugs
  1.2.1 Histamine H2 Receptor Antagonist
  1.2.2 Proton Pump Inhibitor
  1.2.3 Others
1.3 Applications of Anti-ulcer Drugs
  1.3.1 First Level Hospital
  1.3.2 Two Level Hospital
  1.3.3 Three Level Hospital
  1.3.4 Others
1.4 Anti-ulcer Drugs Market by Regions
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Italy Status and Prospect (2011-2021)
  1.4.5 Spain Status and Prospect (2011-2021)
  1.4.6 Russia Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Anti-ulcer Drugs (2011-2021)
  1.5.1 Europe Anti-ulcer Drugs Sales, Revenue and Price (2011-2021)
  1.5.2 Europe Anti-ulcer Drugs Sales and Growth Rate (2011-2021)
  1.5.3 Europe Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)

2 EUROPE ANTI-ULCER DRUGS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Anti-ulcer Drugs Market Competition by Manufacturers
  2.1.1 Europe Anti-ulcer Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Anti-ulcer Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Anti-ulcer Drugs (Volume and Value) by Type
  2.2.1 Europe Anti-ulcer Drugs Sales and Market Share by Type (2011-2021)
  2.2.2 Europe Anti-ulcer Drugs Revenue and Market Share by Type (2011-2021)
2.3 Europe Anti-ulcer Drugs (Volume and Value) by Regions
  2.3.1 Europe Anti-ulcer Drugs Sales and Market Share by Regions (2011-2021)
  2.3.2 Europe Anti-ulcer Drugs Revenue and Market Share by Regions (2011-2021)
2.4 Europe Anti-ulcer Drugs (Volume) by Application

3 GERMANY ANTI-ULCER DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Anti-ulcer Drugs Sales and Value (2011-2021)
  3.1.1 Germany Anti-ulcer Drugs Sales and Growth Rate (2011-2021)
  3.1.2 Germany Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
  3.1.3 Germany Anti-ulcer Drugs Sales Price Trend (2011-2021)
3.2 Germany Anti-ulcer Drugs Sales and Market Share by Manufacturers
3.3 Germany Anti-ulcer Drugs Sales and Market Share by Type
3.4 Germany Anti-ulcer Drugs Sales and Market Share by Applications

4 UK ANTI-ULCER DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 UK Anti-ulcer Drugs Sales and Value (2011-2021)
  4.1.1 UK Anti-ulcer Drugs Sales and Growth Rate (2011-2021)
  4.1.2 UK Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
  4.1.3 UK Anti-ulcer Drugs Sales Price Trend (2011-2021)
4.2 UK Anti-ulcer Drugs Sales and Market Share by Manufacturers
4.3 UK Anti-ulcer Drugs Sales and Market Share by Type
4.4 UK Anti-ulcer Drugs Sales and Market Share by Applications

5 FRANCE ANTI-ULCER DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 France Anti-ulcer Drugs Sales and Value (2011-2021)
  5.1.1 France Anti-ulcer Drugs Sales and Growth Rate (2011-2021)
  5.1.2 France Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
  5.1.3 France Anti-ulcer Drugs Sales Price Trend (2011-2021)
5.2 France Anti-ulcer Drugs Sales and Market Share by Manufacturers
5.3 France Anti-ulcer Drugs Sales and Market Share by Type
5.4 France Anti-ulcer Drugs Sales and Market Share by Applications

6 ITALY ANTI-ULCER DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Italy Anti-ulcer Drugs Sales and Value (2011-2021)
  6.1.1 Italy Anti-ulcer Drugs Sales and Growth Rate (2011-2021)
  6.1.2 Italy Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
  6.1.3 Italy Anti-ulcer Drugs Sales Price Trend (2011-2021)
6.2 Italy Anti-ulcer Drugs Sales and Market Share by Manufacturers
6.3 Italy Anti-ulcer Drugs Sales and Market Share by Type
6.4 Italy Anti-ulcer Drugs Sales and Market Share by Applications

7 RUSSIA ANTI-ULCER DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Russia Anti-ulcer Drugs Sales and Value (2011-2021)
  7.1.1 Russia Anti-ulcer Drugs Sales and Growth Rate (2011-2021)
  7.1.2 Russia Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
  7.1.3 Russia Anti-ulcer Drugs Sales Price Trend (2011-2021)
7.2 Russia Anti-ulcer Drugs Sales and Market Share by Manufacturers
7.3 Russia Anti-ulcer Drugs Sales and Market Share by Type
7.4 Russia Anti-ulcer Drugs Sales and Market Share by Applications

8 SPAIN ANTI-ULCER DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Anti-ulcer Drugs Sales and Value (2011-2021)
  8.1.1 Spain Anti-ulcer Drugs Sales and Growth Rate (2011-2021)
  8.1.2 Spain Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
  8.1.3 Spain Anti-ulcer Drugs Sales Price Trend (2011-2021)
8.2 Spain Anti-ulcer Drugs Sales and Market Share by Manufacturers
8.3 Spain Anti-ulcer Drugs Sales and Market Share by Type
8.4 Spain Anti-ulcer Drugs Sales and Market Share by Applications

9 EUROPE ANTI-ULCER DRUGS MANUFACTURERS ANALYSIS

9.1 Novartis
  9.1.1 Company Basic Information,Manufacturing Base and Competitors
  9.1.2 Anti-ulcer Drugs Product Type and Technology
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Anti-ulcer Drugs Sales, Revenue, Price of Novartis (2015 and 2016)
9.2 Pfizer, Inc.
  9.2.1 Company Basic Information,Manufacturing Base and Competitors
  9.2.2 Anti-ulcer Drugs Product Type and Technology
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Anti-ulcer Drugs Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
9.3 Roche
  9.3.1 Company Basic Information,Manufacturing Base and Competitors
  9.3.2 Anti-ulcer Drugs Product Type and Technology
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Anti-ulcer Drugs Sales, Revenue, Price of Roche (2015 and 2016)
9.4 Sanofi
  9.4.1 Company Basic Information,Manufacturing Base and Competitors
  9.4.2 Anti-ulcer Drugs Product Type and Technology
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 Anti-ulcer Drugs Sales, Revenue, Price of Sanofi (2015 and 2016)
9.5 Merck & Co., Inc.
  9.5.1 Company Basic Information,Manufacturing Base and Competitors
  9.5.2 Anti-ulcer Drugs Product Type and Technology
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Anti-ulcer Drugs Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
9.6 GlaxoSmithKline plc
  9.6.1 Company Basic Information,Manufacturing Base and Competitors
  9.6.2 Anti-ulcer Drugs Product Type and Technology
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Anti-ulcer Drugs Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
9.7 Johnson & Johnson
  9.7.1 Company Basic Information,Manufacturing Base and Competitors
  9.7.2 Anti-ulcer Drugs Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Anti-ulcer Drugs Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
9.8 AstraZeneca plc.
  9.8.1 Company Basic Information,Manufacturing Base and Competitors
  9.8.2 Anti-ulcer Drugs Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Anti-ulcer Drugs Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
9.9 Eli Lilly and Company
  9.9.1 Company Basic Information,Manufacturing Base and Competitors
  9.9.2 Anti-ulcer Drugs Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Anti-ulcer Drugs Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
9.10 Abbvie
  9.10.1 Company Basic Information,Manufacturing Base and Competitors
  9.10.2 Anti-ulcer Drugs Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Anti-ulcer Drugs Sales, Revenue, Price of Abbvie (2015 and 2016)
9.11 AMGen
  9.11.1 Company Basic Information,Manufacturing Base and Competitors
  9.11.2 Anti-ulcer Drugs Product Type and Technology
    9.11.2.1 Type I
    9.11.2.2 Type II
  9.11.3 Anti-ulcer Drugs Sales, Revenue, Price of AMGen (2015 and 2016)
9.12 Teva Pharmaceutical Industries Ltd.
  9.12.1 Company Basic Information,Manufacturing Base and Competitors
  9.12.2 Anti-ulcer Drugs Product Type and Technology
    9.12.2.1 Type I
    9.12.2.2 Type II
  9.12.3 Anti-ulcer Drugs Sales, Revenue, Price of Teva Pharmaceutical Industries Ltd. (2015 and 2016)
9.13 Bayer AG
  9.13.1 Company Basic Information,Manufacturing Base and Competitors
  9.13.2 Anti-ulcer Drugs Product Type and Technology
    9.13.2.1 Type I
    9.13.2.2 Type II
  9.13.3 Anti-ulcer Drugs Sales, Revenue, Price of Bayer AG (2015 and 2016)
9.14 Bristol-Myers Squibb
  9.14.1 Company Basic Information,Manufacturing Base and Competitors
  9.14.2 Anti-ulcer Drugs Product Type and Technology
    9.14.2.1 Type I
    9.14.2.2 Type II
  9.14.3 Anti-ulcer Drugs Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
9.15 Astellas Pharma
  9.15.1 Company Basic Information,Manufacturing Base and Competitors
  9.15.2 Anti-ulcer Drugs Product Type and Technology
    9.15.2.1 Type I
    9.15.2.2 Type II
  9.15.3 Anti-ulcer Drugs Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
9.16 Daiichi Sankyo
  9.16.1 Company Basic Information,Manufacturing Base and Competitors
  9.16.2 Anti-ulcer Drugs Product Type and Technology
    9.16.2.1 Type I
    9.16.2.2 Type II
  9.16.3 Anti-ulcer Drugs Sales, Revenue, Price of Daiichi Sankyo (2015 and 2016)
9.17 Abbott Laboratories
  9.17.1 Company Basic Information,Manufacturing Base and Competitors
  9.17.2 Anti-ulcer Drugs Product Type and Technology
    9.17.2.1 Type I
    9.17.2.2 Type II
  9.17.3 Anti-ulcer Drugs Sales, Revenue, Price of Abbott Laboratories (2015 and 2016)
9.18 Yangtze River Pharmaceutical Group
  9.18.1 Company Basic Information,Manufacturing Base and Competitors
  9.18.2 Anti-ulcer Drugs Product Type and Technology
    9.18.2.1 Type I
    9.18.2.2 Type II
  9.18.3 Anti-ulcer Drugs Sales, Revenue, Price of Yangtze River Pharmaceutical Group (2015 and 2016)
9.19 BAX
  9.19.1 Company Basic Information,Manufacturing Base and Competitors
  9.19.2 Anti-ulcer Drugs Product Type and Technology
    9.19.2.1 Type I
    9.19.2.2 Type II
  9.19.3 Anti-ulcer Drugs Sales, Revenue, Price of BAX (2015 and 2016)
9.20 Taishō Seiyaku Kabushiki-gaisha
  9.20.1 Company Basic Information,Manufacturing Base and Competitors
  9.20.2 Anti-ulcer Drugs Product Type and Technology
    9.20.2.1 Type I
    9.20.2.2 Type II
  9.20.3 Anti-ulcer Drugs Sales, Revenue, Price of Taishō Seiyaku Kabushiki-gaisha (2015 and 2016)

10 ANTI-ULCER DRUGS TECHNOLOGY AND DEVELOPMENT TREND

10.1 Anti-ulcer Drugs Technology Analysis
10.2 Anti-ulcer Drugs Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES AND FIGURES

Figure Picture of Anti-ulcer Drugs
Table Classification of Anti-ulcer Drugs
Figure Europe Sales Market Share of Anti-ulcer Drugs by Types in 2015
Figure Histamine H2 Receptor Antagonist Picture
Figure Proton Pump Inhibitor Picture
Figure Others Picture
Table Applications of Anti-ulcer Drugs
Figure Europe Sales Market Share of Anti-ulcer Drugs by Applications in 2015
Figure First Level Hospital Examples
Figure Two Level Hospital Examples
Figure Three Level Hospital Examples
Figure Others Examples
Figure Germany Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
Figure France Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
Figure UK Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
Figure Italy Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
Figure Spain Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
Figure Russia Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
Table Europe Anti-ulcer Drugs Sales, Revenue and Price (2011-2021)
Figure Europe Anti-ulcer Drugs Sales and Growth Rate (2011-2021)
Figure Europe Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
Table Europe Anti-ulcer Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Anti-ulcer Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Anti-ulcer Drugs Sales Share by Manufacturers
Figure 2016 Anti-ulcer Drugs Sales Share by Manufacturers
Table Europe Anti-ulcer Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Anti-ulcer Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Anti-ulcer Drugs Revenue Share by Manufacturers
Table 2016 Europe Anti-ulcer Drugs Revenue Share by Manufacturers
Table Europe Anti-ulcer Drugs Sales and Market Share by Type (2011-2021)
Table Europe Anti-ulcer Drugs Sales Share by Type (2011-2021)
Figure Sales Market Share of Anti-ulcer Drugs by Type (2011-2021)
Figure Europe Anti-ulcer Drugs Sales Growth Rate by Type (2011-2021)
Table Europe Anti-ulcer Drugs Revenue and Market Share by Type (2011-2021)
Table Europe Anti-ulcer Drugs Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Anti-ulcer Drugs by Type (2011-2021)
Figure Europe Anti-ulcer Drugs Revenue Growth Rate by Type (2011-2021)
Table Europe Anti-ulcer Drugs Sales and Market Share by Regions (2011-2021)
Table Europe Anti-ulcer Drugs Sales Share by Regions (2011-2021)
Figure Sales Market Share of Anti-ulcer Drugs by Regions (2011-2021)
Figure Europe Anti-ulcer Drugs Sales Growth Rate by Regions (2011-2021)
Table Europe Anti-ulcer Drugs Revenue and Market Share by Regions (2011-2021)
Table Europe Anti-ulcer Drugs Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Anti-ulcer Drugs by Regions (2011-2021)
Figure Europe Anti-ulcer Drugs Revenue Growth Rate by Regions (2011-2021)
Table Europe Anti-ulcer Drugs Sales and Market Share by Application (2011-2021)
Table Europe Anti-ulcer Drugs Sales Share by Application (2011-2021)
Figure Sales Market Share of Anti-ulcer Drugs by Application (2011-2021)
Figure Europe Anti-ulcer Drugs Sales Growth Rate by Application (2011-2021)
Figure Germany Anti-ulcer Drugs Sales and Growth Rate (2011-2021)
Figure Germany Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
Figure Germany Anti-ulcer Drugs Sales Price Trend (2011-2021)
Table Germany Anti-ulcer Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Anti-ulcer Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Anti-ulcer Drugs Sales by Type (2015 and 2016)
Table Germany Anti-ulcer Drugs Market Share by Type (2015 and 2016)
Table Germany Anti-ulcer Drugs Sales by Applications (2015 and 2016)
Table Germany Anti-ulcer Drugs Market Share by Applications (2015 and 2016)
Figure UK Anti-ulcer Drugs Sales and Growth Rate (2011-2021)
Figure UK Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
Figure UK Anti-ulcer Drugs Sales Price Trend (2011-2021)
Table UK Anti-ulcer Drugs Sales by Manufacturers (2015 and 2016)
Table UK Anti-ulcer Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Anti-ulcer Drugs Sales by Type (2015 and 2016)
Table UK Anti-ulcer Drugs Market Share by Type (2015 and 2016)
Table UK Anti-ulcer Drugs Sales by Applications (2015 and 2016)
Table UK Anti-ulcer Drugs Market Share by Applications (2015 and 2016)
Figure France Anti-ulcer Drugs Sales and Growth Rate (2011-2021)
Figure France Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
Figure France Anti-ulcer Drugs Sales Price Trend (2011-2021)
Table France Anti-ulcer Drugs Sales by Manufacturers (2015 and 2016)
Table France Anti-ulcer Drugs Market Share by Manufacturers (2015 and 2016)
Table France Anti-ulcer Drugs Sales by Type (2015 and 2016)
Table France Anti-ulcer Drugs Market Share by Type (2015 and 2016)
Table France Anti-ulcer Drugs Sales by Applications (2015 and 2016)
Table France Anti-ulcer Drugs Market Share by Applications (2015 and 2016)
Figure Italy Anti-ulcer Drugs Sales and Growth Rate (2011-2021)
Figure Italy Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
Figure Italy Anti-ulcer Drugs Sales Price Trend (2011-2021)
Table Italy Anti-ulcer Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Anti-ulcer Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Anti-ulcer Drugs Sales by Type (2015 and 2016)
Table Italy Anti-ulcer Drugs Market Share by Type (2015 and 2016)
Table Italy Anti-ulcer Drugs Sales by Applications (2015 and 2016)
Table Italy Anti-ulcer Drugs Market Share by Applications (2015 and 2016)
Figure Russia Anti-ulcer Drugs Sales and Growth Rate (2011-2021)
Figure Russia Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
Figure Russia Anti-ulcer Drugs Sales Price Trend (2011-2021)
Table Russia Anti-ulcer Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Anti-ulcer Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Anti-ulcer Drugs Sales by Type (2015 and 2016)
Table Russia Anti-ulcer Drugs Market Share by Type (2015 and 2016)
Table Russia Anti-ulcer Drugs Sales by Applications (2015 and 2016)
Table Russia Anti-ulcer Drugs Market Share by Applications (2015 and 2016)
Figure Spain Anti-ulcer Drugs Sales and Growth Rate (2011-2021)
Figure Spain Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
Figure Spain Anti-ulcer Drugs Sales Price Trend (2011-2021)
Table Spain Anti-ulcer Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Anti-ulcer Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Anti-ulcer Drugs Sales by Type (2015 and 2016)
Table Spain Anti-ulcer Drugs Market Share by Type (2015 and 2016)
Table Spain Anti-ulcer Drugs Sales by Applications (2015 and 2016)
Table Spain Anti-ulcer Drugs Market Share by Applications (2015 and 2016)
Table Novartis Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Novartis (2015 and 2016)
Table Pfizer, Inc. Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
Table Roche Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Roche (2015 and 2016)
Table Sanofi Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Sanofi (2015 and 2016)
Table Merck & Co., Inc. Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
Table GlaxoSmithKline plc Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table AstraZeneca plc. Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
Table Eli Lilly and Company Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
Table Abbvie Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Abbvie (2015 and 2016)
...


More Publications